These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5896349)

  • 1. [Experimental studies on the pulmonary artery ligation. II. Pulmonary artery ligation and rabbit pulmonary tuberculosis with and without INAH treatment].
    Kato Y
    Sapporo Igaku Zasshi; 1965 Dec; 28(6):484-98. PubMed ID: 5896349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tubazid therapy of cavernous pulmonary tuberculosis in rabbits].
    Bondarev IM; Klebanova AA; Novoselova VP
    Probl Tuberk; 1969; 47(1):77-83. PubMed ID: 5380215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of the treatment of pulmonary tuberculosis with INAH preparations in different degrees of tubazid inactivation].
    Kagramanov AI; Ezerskiĭ VF; Ezerskaia EN; Kiroshka IZ; Grigorian VG
    Sov Med; 1973 Jul; 36(7):82-4. PubMed ID: 4776714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental studies on the pulmonary artery ligation. I. Pulmonary artery ligation and its histological consequence].
    Kato Y
    Sapporo Igaku Zasshi; 1965 Dec; 28(6):473-83. PubMed ID: 5896348
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental tuberculosis. V. Effects of ligation of a pulmonary artery on the pulmonary lesions of induced bovine tuberculosis in rabbits.
    SCOTT HW; COLLINS HA; FOSTER JH; AVERY RD
    J Thorac Surg; 1955 May; 29(5):518-23. PubMed ID: 14368650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with fenazid in perperas with respiratory tuberculosis and post-tuberculous changes in the lung].
    Stakhanov VA; Makarov OV; Kaiukova SI; Chernousova LN; Borisova MI; Slastnikova EB
    Probl Tuberk Bolezn Legk; 2004; (2):45-8. PubMed ID: 15137130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological signs of ineffective chemotherapy for experimental destructive pulmonary tuberculosis].
    Erokhin VV
    Probl Tuberk; 1998; (3):61-6. PubMed ID: 9691695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with isoniazid and ethionamide in ulcero-caseous tuberculosis.
    Cornea P; Nisim F; Nicoulescu F
    Ther Hung; 1966; 14(1):24-9. PubMed ID: 5946507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Examining fibrotic process in lung during treatment of chronic murine tuberculosis with lysosomotropic drug isonaizid].
    Filimonov PN; Shkurupiĭ VA; Kurunov IuN; Pupyshev AB; Panasenko SG
    Probl Tuberk; 1999; (1):63-5. PubMed ID: 10199191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bullous cavitations during isoniazid therapy of pulmonary tuberculosis: chemical casectomy].
    PINEYRO JA; BANGUESES E; CARLOTTA D; PIOVANO S
    Torax; 1956; 5(3-4):133-50. PubMed ID: 13422452
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion by isoniazid of hyperacute to chronic pulmonary tuberculosis in mice. II. Histopathology of lungs.
    Mayer E; Salamandra IA
    Am Rev Respir Dis; 1967 Aug; 96(2):220-8. PubMed ID: 4951907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanisms of anti-inflammatory activity of antioxidants in lung tuberculosis].
    Andrzheiuk NI; Kruglova EG; Novosëlova VP
    Probl Tuberk; 1994; (2):49-53. PubMed ID: 8036223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tubazid treatment of cavernous pulmonary tuberculosis in the dog].
    Bondarev IM; Zhigalina LI; Novoselova VP
    Probl Tuberk; 1968; 46(7):74-9. PubMed ID: 5709506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
    N'guessan K; Dosso M; Marchal G; Chavarot P; Romain F; Pescher P; Edy
    Bull Soc Pathol Exot; 2002 Nov; 95(4):265-8. PubMed ID: 12596375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of patients with pulmonary tuberculosis--strong and weak GINK inactivators].
    Katslan IaD
    Probl Tuberk; 1972; 50(3):36-8. PubMed ID: 5037240
    [No Abstract]   [Full Text] [Related]  

  • 17. [Association of isoniazid with proteolytic enzymes in the treatment of pulmonary tuberculosis].
    Rossini G; Nessi G
    G Ital Mal Torace; 1967; 21(2):94-104. PubMed ID: 5602967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Difficulties in the treatment of pulmonary tuberculosis in a patient rapidly inactivating isoniazid (INH)].
    Bednarski Z
    Wiad Lek; 1984 Jun; 37(12):937-40. PubMed ID: 6523868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
    Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological changes in the pulmonary vessels in postvaccinal and infectious allergy in an experiment].
    Maslauskene TP; Stepanov RP
    Probl Tuberk; 1973; 51(8):61-6. PubMed ID: 4201724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.